Esmirtazapine

Esmirtazapine Uses, Dosage, Side Effects, Food Interaction and all others data.

Esmirtazapine, known by the standardized identifier SCH 900265, was under development by Organon to treat insomnia and vasomotor symptoms associated with menopause. Esmirtazapine is the (S)-(+)-enantiomer of mirtazapine and possesses similar overall pharmacology. This includes inverse agonist activity of H1 and 5-HT2 receptors and antagonism of α2-adrenergic receptors. Merck has terminated its internal clinical development program for esmirtazapine as of March 2010.

Table Of contents

• Esmirtazapine
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Esmirtazapine
Generic	Esmirtazapine
Esmirtazapine Other Names	Esmirtazapine
Type
Formula	C17H19N3
Weight	Average: 265.36 Monoisotopic: 265.157897624
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in insomnia and sleep disorders.

Half Life

10 hours

Innovators Monograph

You find simplified version here Esmirtazapine